Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Language
Publication year range
1.
Biochim Biophys Acta Gen Subj ; 1865(9): 129938, 2021 09.
Article in English | MEDLINE | ID: mdl-34062235

ABSTRACT

BACKGROUND: The use of RNA interference (iRNA) therapy has proved to be an interesting target therapy for the cancer treatment; however, siRNAs are unstable and quickly eliminated from the bloodstream. To face these barriers, the use of biocompatible and efficient nanocarriers emerges as an alternative to improve the success application of iRNA to the cancer, including breast cancer. RESULTS: A hybrid nanocarrier composed of calcium phosphate as the inorganic phase and a block copolymer containing polyanions as organic phase, named HNPs, was developed to deliver VEGF siRNA into metastatic breast cancer in mice. The particles presented a rounded shape by TEM images with average size measured by DLS suitable and biocompatible for biomedical applications. The XPS and EDS spectra confirmed the hybrid composition of the nanoparticles. Moreover, after intravenous administration, the particles accumulated mainly in the tumor site and kidneys, which demonstrates the tumor targeting accumulation through the Enhanced Permeability and Retention Effect (EPR). A significant decrease in size of the tumors treated with the nanoparticles containing siVEGF (HNPs-siVEGF) was observed and the reduction was related to enhanced tumor accumulation of siRNA as well as in vivo VEGF silencing at gene and protein levels. CONCLUSION: The hybrid system prepared was successful in promoting the RNAi effect in vivo with very low toxicity. GENERAL SIGNIFICANCE: This study shows the valuable development of a hybrid nanoparticle carrying VEGF siRNA, as well as their tumor targeting, accumulation and reduction in mice triple-negative breast cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Breast Neoplasms/drug therapy , Nanoparticles/chemistry , RNA, Small Interfering/pharmacology , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Animals , Antineoplastic Agents/chemistry , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , Female , Mice , Mice, Inbred BALB C , Particle Size , RNA, Small Interfering/chemistry , Vascular Endothelial Growth Factor A/metabolism
2.
Mater Sci Eng C Mater Biol Appl ; 109: 110555, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32228895

ABSTRACT

Breast cancer is a major cause of death among women worldwide. Resistance to conventional therapies has been observed in HER2-positive breast cancer patients, indicating the need for more effective treatments. Small interfering RNA (siRNA) therapy is an attractive strategy against HER2-positive tumors, but its success depends largely on the efficient delivery of agents to target tissues. In this study, we prepared a magnetic hybrid nanostructure composed of iron oxide nanoparticles coated with caffeic acid and stabilized by layers of calcium phosphate and PEG-polyanion block copolymer for incorporation of siRNA. Transmission electron microscopy images showed monodisperse, neutrally charged compact spheres sized <100 nm. Dynamic light scattering and nanoparticle tracking analysis revealed that the nanostructure had an average hydrodynamic diameter of 130 nm. Nanoparticle suspensions remained stable over 42 days of storage at 4 and 25 °C. Unloaded caffeic acid-magnetic calcium phosphate (Caf-MCaP) nanoparticles were not cytotoxic, and loaded nanoparticles were successfully taken up by the HER2-positive breast cancer cell line HCC1954, even more so under magnetic guidance. Nanoparticles escaped endosomal degradation and delivered siRNA into the cytoplasm, inducing HER2 gene silencing.


Subject(s)
Breast Neoplasms , Drug Delivery Systems , Magnetic Fields , Nanoparticles , RNA, Small Interfering , Receptor, ErbB-2 , Animals , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , Female , Humans , Mice , NIH 3T3 Cells , Nanoparticles/chemistry , Nanoparticles/therapeutic use , RNA, Small Interfering/chemistry , RNA, Small Interfering/genetics , RNA, Small Interfering/pharmacology , Receptor, ErbB-2/antagonists & inhibitors , Receptor, ErbB-2/genetics , Receptor, ErbB-2/metabolism
3.
Org Biomol Chem ; 17(12): 3218-3224, 2019 03 20.
Article in English | MEDLINE | ID: mdl-30840013

ABSTRACT

The capacity of hydrazone bonds to readily undergo component exchange processes sees their extensive utilization in dynamic combinatorial chemistry. The kinetics of hydrazone exchange are optimal at pH ∼4.5, which limits the use of hydrazone-based dynamic combinatorial libraries, particularly for biological targets which are only stable at near-neutral pH values. It would thus be advantageous if hydrazone exchange proceeded with faster rates at pH values closer to neutral. We experimentally and computationally evaluated the hypothesis that hydrazones possessing neighbouring acidic or basic functional groups within the carbonyl-derived moitety of the hydrazone would enhance exchange rates. Our work suggests that judiciously placed N- or O-hydrogen bond acceptors within the carbonyl-derived moiety of the hydrazone stabilize transition states via hydrogen bonding interactions, providing a valuable boost to exchange kinetics at near-neutral pH values. We anticipate these findings will be of interest in dynamic combinatorial chemistry, dynamic covalent polymers/materials, functionalized nanoparticles and interlocked molecules, all of which may benefit from hydrazone exchange processes able to operate at near-neutral pH values.

4.
Mater Sci Eng C Mater Biol Appl ; 99: 1182-1190, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30889652

ABSTRACT

Short interfering RNA (siRNA) showed to be a viable alternative to a better prognosis in cancer therapy. Nevertheless, the successful application of this strategy still depends on the development of nanocarriers for the safe delivery of siRNA into the diseased tissue, which mostly occurs by passive accumulation. When an external magnetic field is applied, magnetic nanoparticles biodistribution is partially modulated to favor accumulation in a target tissue. In this work we designed a novel magnetic responsive siRNA nanocarrier. The new delivery system is composed of superparamagnetic iron oxide nanoparticles (SPIONs) coated with calcium phosphate (CaP) and PEG-polyanion block copolymers, which are known to be biocompatible. The nanoparticles presented rounded shape with small size and narrow distribution suitable for biomedical applications. TEM images showed dark spheres in the core surrounded by a lower electron density material in the corona. The X-ray photoelectron spectra (XPS) confirmed CaP-polymer coating of the magnetic core. In addition, the coating procedure did not affect the superparamagnetic property as showed using a vibrating sample magnetometer (VSM). With a high loading efficiency (80%), the nanoparticles enhanced vascular endothelium growth factor (VEGF) silencing in breast cancer cells in vitro, at gene and protein levels (~60% and 40%, respectively), without associated toxicity. Iron and siRNA quantification showed that the novel nanoparticles move towards a magnetic source carrying siRNA molecules. Therefore, these novel nanoparticles are a promising tool for cancer therapy based on RNAi effect, added by a magnetic capability to further modulate siRNA accumulation in the target tissue.


Subject(s)
Breast Neoplasms/metabolism , Magnetics , Nanoparticles/chemistry , RNA, Small Interfering/administration & dosage , Cell Line, Tumor , Cell Survival , Female , Gene Silencing , Humans , Magnetic Fields , Nanoparticles/ultrastructure , Particle Size , Time Factors , Vascular Endothelial Growth Factor A/metabolism
5.
Food Chem ; 275: 123-134, 2019 Mar 01.
Article in English | MEDLINE | ID: mdl-30724178

ABSTRACT

We formulated and characterised two alginate blends for the encapsulation of stevia extract (SE) via ionic gelation through an extrusion technique. Calcium chloride in SE and calcium chloride solutions were assessed as crosslinkers to overcome phenolic losses by diffusion and increase encapsulation efficiency (EE). Regardless of the blend, all stevia-loaded beads exhibited high EE (62.7-101.0%). The size of the beads decreased as EE increased. Fourier transform infrared analysis showed increased hydrogen bonding between SE and alginates, confirming the successful incorporation of SE within the matrix. Untargeted metabolomics profiling identified 479 free and encapsulated polyphenolic compounds. Flavonoids (catechin and luteolin equivalents) were predominant in SE whereas tyrosols and 5-pentadecylresorcinol equivalents were predominant in all bead formulations. Three-common discriminant compounds were exclusive to each blend and were inversely affected by the crosslinking conditions. Both alginate blends have been shown to be feasible as carrier systems of stevia extracts independent of crosslinking conditions.


Subject(s)
Alginates/chemistry , Drug Compounding/methods , Plant Extracts/chemistry , Polyphenols/chemistry , Stevia/chemistry , Gels/chemistry , Hydrogen Bonding , Metabolomics/methods , Microscopy, Electron, Scanning , Phenols/chemistry , Plant Extracts/analysis , Polyphenols/analysis , Secondary Metabolism , Spectroscopy, Fourier Transform Infrared , Stevia/metabolism
6.
Sci Total Environ ; 660: 1264-1273, 2019 Apr 10.
Article in English | MEDLINE | ID: mdl-30743921

ABSTRACT

Humans are potentially exposed to multiple nanoparticles kinds through nanotechnology-based consumer products. There is insufficient data on the in vivo toxicity of nanotechnology products, as well as no data on the possible toxicity, including genotoxicity and reproductive toxicity of co-exposure to different kind of nanoparticles. In this work, solid lipid nanoparticles (SLNs) and superparamagnetic iron oxide nanoparticles (SPIONs) were selected for evaluation of a hypothetical condition of in vivo co-exposure. Genotoxicity of SPIONs and SLNs was performed separately and in 1:1 mixture in mice. Bone marrow micronucleus assay, sperm morphology test, and sperm count were carried out. Also, the serum ALT and AST activities; and hematological parameters of the treated mice were analyzed. The results showed a significant increase (p < 0.05) in micronucleated polychromatic erythrocytes (MNPCE) and nuclear abnormalities (NA) in SPIONs, SLNs and their mixture treated mice. The mixture induced the highest frequency of MNPCE and NA. A similar result was observed in the sperm morphology test, with the mixture inducing the highest sperm abnormalities, followed by SLNs and the least by SPIONs. Significant alteration to RDW, MCHC, MCV, GRAN, and platelets, as well as increased activities of serum AST were observed in the mice treated with a mixture of the two kinds of nanoparticles. Calculation of interaction factor showed a possible synergistic effect between SPIONs and SLNs in MNPCE, NA and sperm morphology studied. Even as a hypothetical scenario of co-exposure to SLNs and SPIONs, this study showed, for the first time, that co-exposure to SPIONs and SLNs is more genotoxic to somatic and germ cells than their individual exposure.


Subject(s)
Ferric Compounds/toxicity , Lipids/toxicity , Nanoparticles/toxicity , Nanotechnology , Oxidative Stress/drug effects , Animals , Bone Marrow/drug effects , DNA Damage , Male , Mice , Micronucleus Tests , Sperm Count , Spermatozoa/drug effects
7.
Rev. bras. farmacogn ; 25(5): 513-521, Sept.-Oct. 2015. tab, graf
Article in English | LILACS | ID: lil-765075

ABSTRACT

ABSTRACTChlorogenic and caffeic acids are bioactive phenolic compounds present in Cecropia glaziovii Snethl., Urticaceae, products that have been used as analytical markers. This paper reports a chemometric study aimed at improving chromatographic performance for quantification of these markers by RP-HPLC. The organic to aqueous content ratio, the acid content of the mobile phase, and the elution method were analyzed using a Response Surface Methodology IV-Optimal design. The resolution between peaks, retention time, tailing and retention factors, number of theoretical plates and peak widths were evaluated. The optimized conditions were mathematically determined as (A) trifluoroacetic acid 0.05% (v/v), (B) 12% (v/v) acetonitrile and (C) increasing gradient. The method was considered specific, fast, precise, reliable and linear in the ranges of 1.0–200.0 and 2.5–100.0 µg/ml for the chlorogenic and caffeic acids, respectively. The adequate conditions to separate and quantify both phenolic acids in C. glaziovii products were demonstrated. Satisfactory resolution was achieved when compared to a previously published chromatographic method which is unable to separate the chlorogenic acid and an interfering compound presented under certain extractive conditions, demonstrating the importance of systematic studies, specifically when analyzing complex plant matrices.

SELECTION OF CITATIONS
SEARCH DETAIL
...